Medicare Enrolled

Dr. Frederic Newman, MD

Gastroenterology · Pensacola, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4531 N DAVIS HWY, Pensacola, FL 32503
8504364563
In practice since 2005 (20 years)
NPI: 1568443299 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Newman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Newman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Newman

Dr. Frederic Newman is a gastroenterology in Pensacola, FL, with 20 years in practice. Based on federal Medicare data, Dr. Newman performed 2,137 Medicare services across 704 unique beneficiaries.

Between the years covered by Open Payments, Dr. Newman received a total of $9,771 from 39 pharmaceutical and/or device companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Newman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 12% volume in FL$ $9,771 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,137
Medicare services
Top 12% in FL for gastroenterology
704
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~107 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Infliximab infusion (Remicade)1,370$27$231
Colonoscopy with biopsy141$127$1,497
Hospital follow-up visit, moderate complexity97$63$237
Upper GI endoscopy with biopsy86$78$1,182
Removal of polyps or growths of large bowel using an endoscope with mechanical snare55$210$1,426
Office visit, established patient (20-29 min)52$62$237
Office visit, established patient (30-39 min)49$89$348
Initial hospital admission, moderate complexity43$103$455
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope37$77$914
Colorectal cancer screening; colonoscopy on individual at high risk37$183$1,091
Diagnostic exam of large bowel using a flexible endoscope23$143$1,500
Administration of chemotherapy into vein, 1 hour or less23$99$1,000
Administration of chemotherapy into vein, each additional hour23$22$300
Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery19$158$1,503
Hospital follow-up visit, low complexity18$40$131
Dilation of esophagus17$41$825
New patient office visit (45-59 min)16$98$542
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk16$172$1,109
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes15$66$343
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.1% high complexity
15.3% medium
20.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,771
Total received (2018-2024)
Avg $1,396/year across 7 years
Top 17% in FL for gastroenterology
39
Companies
253
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,971 (71.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,800 (28.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$501
2023
$2,722
2022
$900
2021
$834
2020
$509
2019
$563
2018
$3,742

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan Inc.
$2,800
Apollo Endosurgery US Inc
$1,671
ABBVIE INC.
$755
Janssen Biotech, Inc.
$633
Takeda Pharmaceuticals U.S.A., Inc.
$598
AbbVie Inc.
$498
AbbVie, Inc.
$494
E.R. Squibb & Sons, L.L.C.
$228
Gilead Sciences, Inc.
$217
Celgene Corporation
$176
Janssen Scientific Affairs, LLC
$171
PFIZER INC.
$168
Cook Medical LLC
$156
Synergy Pharmaceuticals Inc
$133
Ironwood Pharmaceuticals, Inc
$121
Covidien LP
$89
Boston Scientific Corporation
$86
Lumendi LLC
$86
Axonics, Inc.
$68
Ferring Pharmaceuticals Inc.
$58
Medtronic USA, Inc.
$54
Regeneron Healthcare Solutions, Inc.
$50
Nestle HealthCare Nutrition Inc.
$48
Medtronic, Inc.
$39
Shionogi Inc
$37
Braintree Laboratories, Inc.
$34
Daiichi Sankyo Inc.
$34
Merck Sharp & Dohme Corporation
$34
Phathom Pharmaceuticals, Inc.
$32
Mallinckrodt Hospital Products Inc.
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$30
Pharmacosmos Therapeutics Inc.
$23
Merck Sharp & Dohme LLC
$22
Exact Sciences Corporation
$20
NESTLE HEALTHCARE NUTRITION INC.
$19
Olympus America Inc.
$15
GENZYME CORPORATION
$15
Shire North American Group Inc
$15
Intercept Pharmaceuticals, Inc.
$13
Top 3 companies account for 53.5% of total payments
Associated products mentioned in payments ›
Axonics · CLENPIQ · COOK MEDICAL ENDOSCOPIC ULTRASOUND · CREON · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · DiLumen · ENTYVIO · EVIS EXERA III COLONOVIDEOSCOPE · EXALT Model D · EndoFlip · Entyvio · Epclusa · GATTEX · HUMIRA · Humira · INJECTAFER · INTERSTIM · Instinct · LINZESS · Linzess · MAVYRET · MONOFERRIC · Mavyret · Mulpleta · OCALIVA · OverStitch Endoscopic Suturing System · Overstitch · REBYOTA · RINVOQ · SKYRIZI · STELARA · SUPREP · SUPREP BOWEL PREP · TERLIVAZ · TREMFYA · Trulance · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $457 per 100 Medicare services performed
Looking for a gastroenterology in Pensacola?
Compare gastroenterologys in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
27
Per 100K population
8.4
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Newman is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Newman experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Newman performed 1,370 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Newman receive payments from pharmaceutical companies?
Yes. Dr. Newman received a total of $9,771 from 39 companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Newman's costs compare to other gastroenterologys in Pensacola?
Dr. Newman's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Newman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →